Results
1
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
1 companies
Biomark Diagnostics
Market Cap: €44.1m
Develops early-stage cancer diagnostic technology platform to detect and treat cancer.
20B
€0.37
7D
1.6%
1Y
188.4%